Cellular fate of a plant virus immunotherapy candidate

Cowpea mosaic virus (CPMV) is a plant virus that is currently being developed for intratumoral immunotherapy. CPMV relieves the immune system from tumor-induced immunosuppression; reprograms the tumor microenvironment to an activated state whereby the treated and distant tumors are recognized and eradicated. Toward translational studies, we investigated the safety of CPMV, specifically addressing whether pathogenicity would be induced in mammalian cells. We show that murine macrophage immune cells recognize CPMV; however, there is no indication of de novo viral protein synthesis or RNA replication. Furthermore, we show that CPMV does not induce hemolysis, platelet aggregation and plasma coagulation amongst other assays in human blood and immune cells. Taken together, we anticipate that these results will reinforce the development of CPMV as an immunotherapeutic platform.

Authors

Institutions

Publication Details

Journal
Communications Biology
Published
2024-10-24
DOI
https://doi.org/10.1038/s42003-024-06982-0
Citations
15
Primary Topic
Plant Virus Research Studies
Type
article
Field-Weighted Citation Impact
8.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cellular fate of a plant virus immunotherapy candidate

Jie Xu, Zhongchao Zhao, Michael Sierk, Sweta Karan et al.
15 citations
Communications Biology
Plant Virus Research Studies
8.99
article

Cellular fate of a plant virus immunotherapy candidate

Jie Xu, Zhongchao Zhao, Michael Sierk, Sweta Karan, Nicole F. Steinmetz, Daoud Meerzaman, Marina A. Dobrovolskaia, Anthony O. Omole, Jessica Fernanda Affonso de Oliveira, Barry W. Neun, Lucas Sutorus, Qingrong Chen, Edward Cedrone, Jeffrey D. Clogston
article en
15 citations

Abstract

Cowpea mosaic virus (CPMV) is a plant virus that is currently being developed for intratumoral immunotherapy. CPMV relieves the immune system from tumor-induced immunosuppression; reprograms the tumor microenvironment to an activated state whereby the treated and distant tumors are recognized and eradicated. Toward translational studies, we investigated the safety of CPMV, specifically addressing whether pathogenicity would be induced in mammalian cells. We show that murine macrophage immune cells recognize CPMV; however, there is no indication of de novo viral protein synthesis or RNA replication. Furthermore, we show that CPMV does not induce hemolysis, platelet aggregation and plasma coagulation amongst other assays in human blood and immune cells. Taken together, we anticipate that these results will reinforce the development of CPMV as an immunotherapeutic platform.

Communications BiologyVol. 7(1)
National Institutes of Health (US), University of California San Diego (US), Frederick National Laboratory for Cancer Research (US), La Jolla Bioengineering Institute (US), National Cancer Institute (US)
U.S. Department of Health and Human Services, American Cancer Society, Alfred P. Sloan Foundation, F. M. Kirby Foundation, James N. Kirby Foundation, National Institutes of Health, University of California, San Diego, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 2%
Plant Virus Research Studies
8.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.